Latest market price
42.09
+0.62+1.50%
OverviewShort InterestFilings
TEVAQT65Teva Pharmaceutical Industries Limited·NYSE
42.09+1.50%

Latest SEC Filings

Form category
DescriptionFilingDocument
Oct 29, 20268-KCurrent report
Oct 08, 20263Initial statement of beneficial ownership
Sep 22, 20264Statement of changes in beneficial ownership
Sep 22, 20264Statement of changes in beneficial ownership
Sep 21, 2026144Notice of proposed sale of restricted securities
Sep 18, 2026144Notice of proposed sale of restricted securities
Sep 16, 20268-KCurrent report
Sep 14, 202625-NSENotification of removal from listing
Sep 14, 20268-KCurrent report
Sep 14, 20268-A12B/A8-A12B/A
Sep 11, 2026424B5Prospectus
Sep 11, 20268-KCurrent report
Sep 10, 2026FWPFree writing prospectus
Sep 10, 2026FWPFree writing prospectus
Sep 08, 2026424B5Prospectus
Sep 03, 20268-KCurrent report
Sep 03, 20268-KCurrent report
Aug 25, 20264Statement of changes in beneficial ownership
Aug 25, 20264Statement of changes in beneficial ownership
Aug 19, 20264Statement of changes in beneficial ownership
Aug 17, 2026144Notice of proposed sale of restricted securities
Aug 10, 20264Statement of changes in beneficial ownership
Aug 05, 20264Statement of changes in beneficial ownership
Aug 05, 20264Statement of changes in beneficial ownership
Aug 03, 2026144Notice of proposed sale of restricted securities
#1 / 25 of 555
Page
▼
/ 23